Andere Sprachen Ajinomoto Co., Inc. OTC Markets

Aktien

A0B706

US0097071007

AJINY

Markt geschlossen - OTC Markets Andere Börsenplätze 21:59:59 28.06.2024			% 5 Tage	% 1. Jan.
35,24 ^USD	-2,38 %		+1,21 %	-8,15 %

09.05.	Transcript : Ajinomoto Co., Inc., 2024 Earnings Call, May 09, 2024
09.05.	Ajinomoto Co., Inc. (TSE:2802) kündigt einen Aktienrückkauf für 12.500.000 Aktien an, was 2,44% für ¥50.000 Millionen entspricht.	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Ajinomoto Co., Inc. announces an Equity Buyback for 12,500,000 shares, representing 2.44% for ¥50,000 million.	09.05.
Ajinomoto Co., Inc. authorizes a Buyback Plan.	09.05.
Ajinomoto : Enhancing Corporate Value through ASV Management	27.03.
Ajinomoto : Sustainability Initiatives Aimed at Enhancement of Corporate Value	27.03.
TechMagic, Inc. announced that it has received funding from a group of investors	27.03.
Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium	26.03.
Ajinomoto (Malaysia) Closes MYR408 Million Sale of Six Kuala Lumpur Land Plots	12.03.
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.	08.03.
Ajinomoto Co., Inc.'s Equity Buyback announced on November 13, 2023, has closed with 7,003,300 shares, representing 1.35% for ¥39,999.85 million.	07.03.
Tsubame BHB Co., Ltd. announced that it has received ¥5.3 billion in funding from a group of investors	21.02.
Ajinomoto Foods Restates Commitment to Quality Products	15.02.
Inglewood Co., Ltd. announced that it has received funding from Ajinomoto Co., Inc.	31.01.
Ribomic and Ajinomoto Co. Partner for Nucleic Acid Aptamer Research	17.01.
Ribomic Enters Into Drug Research Collaboration with Ajinomoto	17.01.
RIBOMIC Inc. and Ajinomoto Co., Inc. Announce Joint Research Agreement	16.01.
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.	05.01.
New acquisition to support global gene therapy manufacturing	14.11.
Forge Biologics - Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1	14.11.
Japan's Ajinomoto to buy US-based Forge Biologics for $546 million	13.11.
Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1	13.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ajinomoto Co., Inc. OTC Markets

Aktien

A0B706

US0097071007

AJINY

Andere Sprachen

Filter